Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: a randomized, controlled, open-label, parallel group trial https://www.medrxiv.org/content/10.1101/2022.01.30.22269685v2.full.pdf